Acadia Pharmaceuticals Set to Join S&P SmallCap 600
Portfolio Pulse from
Acadia Pharmaceuticals Inc. (ACAD) will join the S&P SmallCap 600, replacing Independent Bank Group Inc. (IBTX), which is being acquired by SouthState Corp. (SSB). The changes will take effect on January 3, 2025.

December 30, 2024 | 10:45 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Independent Bank Group will be removed from the S&P SmallCap 600 due to its acquisition by SouthState Corp.
The removal from the S&P SmallCap 600 is a result of the acquisition by SouthState Corp. This is a neutral event for IBTX as the acquisition terms are already set.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 70
NEUTRAL IMPACT
SouthState Corp. is acquiring Independent Bank Group, which will lead to changes in the S&P indices.
The acquisition of IBTX by SSB is a strategic move, but the immediate impact on SSB's stock price is uncertain as it depends on the market's perception of the acquisition's value.
CONFIDENCE 80
IMPORTANCE 50
RELEVANCE 60
POSITIVE IMPACT
Acadia Pharmaceuticals will be added to the S&P SmallCap 600, which could increase its visibility and attract more investors.
Being added to the S&P SmallCap 600 can increase a company's visibility and attract institutional investors who track the index, potentially leading to a positive impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80